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Staufen1-mediated mRNA decay (SMD)a b s t r a c t
Although non-structural protein 1 (NS1) of inﬂuenza viruses is not essential for virulence, this pro-
tein is involved in host–virus interactions, viral replication, and translation. In particular, NS1 is
known to interact with the host protein, staufen1 (Stau1). This interaction is important for efﬁcient
viral replication. However, the underlying molecular mechanism by which NS1 inﬂuences the viral
life cycle remains obscure. Here, we show using immunoprecipitation and artiﬁcial tethering that
the N-terminus of NS1, NS1(1-73), interacts with Stau1, blocks the Stau1–Upf1 interaction, and con-
sequently inhibits the efﬁciency of Stau1-mediated mRNA decay (SMD), but not nonsense-mediated-
mRNA decay (NMD). The regulation of SMD efﬁciency by NS1 may contribute to building a more
favorable cellular environment for viral replication.
Structured summary of protein interactions:
STAU1-55 physically interacts with UPF1 by anti tag-coimmunoprecipitation (View interaction)
NS1 physically interacts with STAU1-55 by anti tag-coimmunoprecipitation (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction implicated in viral replication [7,8]. However, the underlyingInﬂuenza virus is a negative, single-stranded, and segmented
RNA virus that belongs to the Orthomyxoviridae family [1]. This
virus infects various animals including birds, pigs, horses, and hu-
mans. In humans, viral infection can produce mild symptom such
as chills, fever, sore throat, muscle pains, and headache. But,
depending on the virus strain, death can result; the human mortal-
ity rate ranges from 0.1% to 2% [1].
Inﬂuenza virus contains eight viral RNA segments, which en-
code 11 different polypeptides [2,3]. Segment eight encodes non-
structural protein 1 (NS1), which is exuberantly expressed in host
cells during infection [4,5]. NS1 interacts with a variety of host pro-
teins including interferon (IFN)-inducible 20-50-oligoadenylate syn-
thetase (OAS)/RNase L, retinoic acid inducible gene I (RIG-I),
double-stranded RNA-activated protein kinase (PKR), poly(A)-
binding proteins (PABP) 1 and 2, eukaryotic translation initiation
factor (eIF) 4GI, and staufen1 (Stau1), helping virus escape the anti-
viral mechanisms of host cells and regulating host and viral gene
expression [2,3]. In particular, the interaction of NS1 with Stau1
has long been known [6]. More recently, this interaction has beenmolecular mechanism has so far been poorly characterized.
Human Stau1 protein, which is a double-stranded RNA-binding
protein, is implicated in the regulation of mRNA stability in cul-
tured cells and localization of mRNAs in neuronal cells [9–14]. In
particular, when Stau1 binds to the Stau1-binding site (SBS), which
is a highly-ordered secondary or tertiary structure in the 30
untranslated region (30UTR) of target mRNAs, Stau1 triggers rapid
mRNA degradation [13]. Stau1 can also recognize another type of
SBS, a RNA duplex structure formed by intermolecular base-pairing
between two RNA molecules: an Alu sequence in the 30UTR of the
target mRNA and another Alu sequence in a long non-coding RNA
(lncRNA) [12]. This mode of mRNA degradation triggered by an
interaction between Stau1 and SBS, which is formed by either
intramolecular or intermolecular base-parings, is called Stau1-
mediated mRNA decay (SMD) [9,11–14].
So far, several cellular factors including Stau1, Upf1, and PNRC2
have been characterized to be required for efﬁcient SMD [13,15]. Of
note, Upf1 and PNRC2 are also required for another type of mRNA
decay pathway, nonsense-mediated mRNA decay (NMD) [16–18],
by which aberrant transcripts or normal cellular transcripts
harboring a premature termination codon (PTC) are selectively
recognized and downregulated in the cytoplasm [19–22]. Efﬁcient
SMD is coupled to a translation [13], similar to NMD [23–30].
When a ribosome reaches a translation stop codon, downstream
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ribosome on stop codon may recruit Upf1 along with eukaryotic
translation release factor (eRF) 1 and 3, and SMG1 kinase, as in
NMD [15–18]. Regardless, the recruited Upf1 interacts with PNRC2
via a protein–protein interaction, which links Upf1 and a decap-
ping complex [15,16]. Consequently, the SBS-containing target
mRNA undergoes decapping followed by 50-to-30 exoribonucleolyt-
ic cleavage [13,15,16]. However, how Upf1 activates 30-to-50 exori-
bonucleolytic pathway during SMD remains unknown. The
dynamic regulation of a stability of target mRNAs mediated by
SMD has been implicated in diverse physiological events including
myogenesis and adipogenesis [11,14,15].
In this study,wedelineate theminimal region of NS1 required for
binding toStau1.Andwedemonstrate thatNS1promotes the release
of Upf1 from Stau1-containing complex, consequently inhibiting
SMDefﬁciency. The inhibitory role ofNS1 in hostmRNAdegradation
may build host environment favorable to inﬂuenza viral replication.
2. Materials and methods
2.1. Plasmid constructions
The following constructs were used: phStau155-HA3 [31], pCMV-
Myc-Upf1 [13], pcb-6bs [32], pMS2-HA [13], pcNMS2 [32], and
pcNMS2-Upf2 [32]. NMD reporters were previously described [13].
To construct p3xFLAG-NS1, p3xFLAG (Sigma–Aldrich) was di-
gested with NotI and BglII, and then ligated to a NotI/BglII fragment
of NS1 cDNA [A/Puerto Rico/8/34 (PR8) strain], which was ampli-
ﬁed by PCR using a pCAGGS-NS1 (a kind gift from Dr. K.H. Kim)
and two oligonucleotides: 50-TTGCGGCCGCAAGAATTCCGATGGA
TCCAAACACTGTGTCAAGCTTTCAG-30 (sense) and 50-GCAGAGG-
GAAAAAGA TCTGCTAGCTCGAGC-30 (antisense), where the under-
lined nucleotides specify the NotI and BglII sites, respectively.
To construct p3xFLAG-NS1(1-73), p3xFLAG-NS1(74-207), and
p3xFLAG-NS1(74-230), p3xFLAG-NS1 was digested with NotI and
BglII, and then ligated to a NotI/BglII fragment of PCR-ampliﬁed
NS1(1-73), NS1(74-207), and NS1(74-230) cDNA, respectively.
NS1(1-73), NS1(74-207), and NS1(74-230) cDNAs were ampliﬁed
by PCR using a p3xFLAG-NS1 as a template and two oligonucleo-
tides: 50-TTGCGGCCGCAAGAATTCCGATGGATCCAAACACTGTGTCAA
GCTTTCAG-30 (sense) and 50-GAAGATCTGCTAGCTCGAGCTTCA
GGATTCTTCTTTCAGAATCCGCTCC-30 (antisense) for the ampliﬁca-
tion of NS1(1-73); 50-TTGCGGCCGCAAGAATTCCGGATGA
GGCACTTAAAATGACCATG-30 (sense) and 50-GAAGATCTGCTAGCT
CGAGCTTCAATTACTGCTTCTCCAAGCGAATCTC-30 (antisense) for
the ampliﬁcation of NS1(74-207); 50-TTGCGGCCGCAAGAATT
CCGGATGAGGCACTTAAAATGACCATG-30 (sense) and 50-GCAGA
GGGAAAAAGATCTGCTAGCTCGAGC-30 (antisense) for the ampliﬁ-
cation of NS1(74-230), where the underlined nucleotides specify
the NotI and BglII sites, respectively.
To construct plasmid pMS2-HA-Stau1, which encodes N-termi-
nal oligomerization-defective MS2 coat protein followed by a HA
tag and full-length human Stau1 cDNA, a XhoI/NotI fragment of
pMS2-HA-PNRC2 [16] was ligated to a PCR-ampliﬁed fragment
that contains human Stau1 cDNA and was digested with XhoI
and NotI. Human Stau1 cDNA was ampliﬁed using phStau155-
HA3 [31] and two oligonucleotides: 50-CCGCTC-
GAGATGAAACTTGGAAAAAAACCAATGTATAAG-30 (sense) and 50-
ATAAGAATGCGGCCGCTCAGCACCTCCCACACACAGACATTGGTCC-30
(antisense), where the underlined nucleotides specify the XhoI and
NotI sites, respectively.
2.2. Cell culture, transfections, and immunoprecipitation
HeLa cells and HEK293T cells were cultured in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM; Hyclone) in the presence of10% fetal bovine serum (FBS; Hyclone). For tethering and immu-
nostaining experiments, cells were transiently transfected with
indicated plasmids using turbofect (Fermentas) or Lipofectamine
2000 (Invitrogen). For immunoprecipitation (IP), performed as de-
scribed previously [15,16,27,29], cells were transiently transfec-
ted by calcium phosphate precipitation with the indicated
plasmids.
2.3. Western blotting
Expression levels of transfected plasmids and identities of co-
immunopuriﬁed proteins were determined by Western blotting
according to standard protocol. The following antibodies were
used: FLAG (Sigma), HA (Roche), Myc (Calbiochem), Upf1 (gift from
Dr. Lynne E. Maquat), phospho-S1078-Upf1 [15], phospho-S1096-
Upf1 [15], Upf2 [15], and b-actin (Sigma).
2.4. Tethering assay
HeLa cells were transiently transfected with 0.15 lg of pcb-6bs,
0.05 lg of phCMV-MUP, 0.5 lg of effector plasmid, and 0.5 lg of
plasmid expressing either NS1(WT) or its variants using Turbofect
(Fermentas), as previously described [15,16,29]. Two days later,
the cells were harvested and total cell RNA and protein were puri-
ﬁed using TRIzol Reagent (Invitrogen).
2.5. RT-PCR using a-[32P]-dATP and speciﬁc oligonucleotides
RT-PCR using speciﬁc oligonucleotides and a-[32P]-dATP (Perk-
inElmer NEN) was performed as described previously [15,16]. The
RT-PCR products were separated on a 5% acrylamide gel, visualized
by PhosphorImaging (BAS-2500; Fuji Photo Film), and then quanti-
tated by Multigauge (Fuji Photo Film). The sets of speciﬁc oligonu-
cleotides used for the ampliﬁcation of mRNAs are listed in
Supplementary Table S1.
2.6. Quantitative real-time RT-PCR
Quantitative real-time PCR (qRT-PCR) analyses were carried
out using the LightCycler™ system (Roche Diagnostics,
Mannheim, Germany), as described previously [14–16,29]. The
relative levels of expression of the tested mRNAs were calculated
from the means obtained from three independently performed
experiments. Melting curves of the PCR products were performed
for quality control. The speciﬁc oligonucleotide sets used for
the ampliﬁcation of mRNAs are listed in Supplementary
Table S1.3. Results
3.1. N-terminal RNA-binding domain of NS1 is required for binding to
Stau1
Stau1 was previously identiﬁed as NS1-interacting protein
using yeast two-hybrid screening system [6]. Prior to testing the
possible role of NS1 in cellular gene expression, we ﬁrst test using
immunoprecipitation (IP) whether NS1 and Stau1 associate with
each other. To this end, HEK293T cells were transiently co-trans-
fected with plasmids expressing N-terminal three tandem repeats
of FLAG sequence (3xFLAG)-tagged NS1 wild-type (WT), and C-ter-
minal three tandem repeats of HA (HA3)-tagged Stau1 (Stau155-
HA3) (Fig. 1A). The results of IP revealed that Stau155-HA3 co-
immunopuriﬁed with 3xFLAG-NS1 in a partially RNase-resistant
manner (Fig. 1A, upper), consistent with previous report [6–8],
indicating that NS1 interacts with Stau1. Efﬁcient removal of RNAs
A B
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Fig. 1. Inﬂuenza viral non-structural protein NS1 interacts with host protein Stau1. (A) Immunoprecipitation (IP) of 3xFLAG-NS1. HEK293T cells were transiently co-
transfected with plasmids expressing Stau155-HA3 and either 3xFLAG or 3xFLAG-NS1. Two days after transfection, total-cell extracts were either untreated or treated with
RNase A and then subjected to IPs using a-FLAG antibody-conjugated agarose beads andWestern blotting using indicated antibodies (upper). The level of endogenous GAPDH
mRNA was analyzed by RT-PCR using a-[32P]-dATP and speciﬁc oligonucleotides to conﬁrm that the RNase A digestion was complete (lower). The four leftmost lanes, in
which twofold serial dilutions of cellular RNAs were analyzed, demonstrated that the conditions used for RT-PCR were sufﬁciently quantitative. (B) Schematic representation
of full-length NS1(WT) and its deletion variants used in our study. 3xFLAG, three tandem repeats of FLAG tag; RBD, RNA-binding domain. (C) IPs of NS1(WT) and its variants
using the a-FLAG antibody. Samples before or after IPs were analyzed by Western blotting using antibody against FLAG, HA, or b-actin (left). For the demonstration that the
RNase A digestion was complete, the level of endogenous GAPDH mRNA was analyzed by RT-PCR using a-[32P]-dATP (right). Each panel of results is representative of at least
three independently performed transfections followed by IPs. MW, molecular weight; bps, base-pairs.
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glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNAs
using a-[32P]-dATP and speciﬁc oligonucleotides (Fig. 1A, lower).
So far, the region of NS1 important for binding to Stau1 has not
been clearly characterized. To determine the minimal region of
NS1 that interacts with Stau1, we ﬁrst constructed several plas-
mids expressing deletion variants of NS1: 3xFLAG-NS1(1-73) con-
taining an RNA-binding domain (RBD), 3xFLAG-NS1(74-207)
containing the effector domain, and 3xFLAG-NS1(74-230) contain-
ing both the effector domain and the C-terminal tail region
(Fig. 1B). Next, we performed IPs using the extracts of cells tran-siently co-transfected with plasmids expressing Stau155-HA3 and
either 3xFLAG-NS1(WT) or its deletion variant. To exclude a
RNA-mediated indirect interaction, cell extracts were treated with
RNase A before IP. The IP results using FLAG antibody showed that
Stau155-HA3 co-puriﬁed with 3xFLAG-NS1(WT) and 3xFLAG-
NS1(1-73), but not 3xFLAG-NS1(74-207) and 3xFLAG-NS1(74-
230) (Fig. 1C, left) upon RNase A treatment. The complete removal
of cellular mRNAs by RNase A treatment was demonstrated by RT-
PCR of GAPDH mRNA (Fig. 1C, right). The collective results suggest
that NS1(1-73) containing RBD is sufﬁcient for binding to Stau1 in
a RNA-independent manner.
AB C D E
F
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Fig. 2. Expression of NS1 inhibits SMD but not NMD. (A–E) HeLa cells were transiently transfected with plasmid expressing either 3xFLAG or 3xFLAG-NS1. (A) Western
blotting to show the expressions of 3xFLAG-NS1. (B and C) qRT-PCR of endogenous SMD substrates. The levels of cellular KLF2 mRNA were normalized to the levels of cellular
GAPDH mRNA. Normalized levels of KLF2 in the presence of 3xFLAG were arbitrarily set to one (B). Cellular IL7R mRNAs were also analyzed (C), as in Fig. 2B. (D and E) qRT-
PCRs of endogenous NMD substrates. The levels of cellular IARS mRNA (D) or COMMD7 mRNA (E) were normalized to the levels of cellular GAPDH mRNA. (F–H) HeLa cells
were transiently co-transfected with (i) NMD reporter plasmids, pmCMV-Gl and pmCMV-GPx1 that are either Norm or Ter, (ii) the reference plasmid phCMV-MUP, and (iii)
either p3xFLAG or p3xFLAG-NS1(WT). (F) Western blotting of NS1 using a-FLAG and b-actin antibodies. To demonstrate that Western blotting was semi-quantitative in our
study, threefold serial dilutions of total-cell extracts were loaded in the four left-most lanes. (G) qRT-PCRs of Gl Norm and Ter mRNA. The levels of Gl mRNAs were normalized
to the level of MUP mRNA. The normalized levels of Gl Norm mRNA were set to 100%. (H) qRT-PCRs of GPx1 Norm and Ter mRNA. As in Fig. 2G, except GPx1 mRNAs were
analyzed. The columns and bars in each panel represent the mean and standard deviation of three independently performed transfections and qRT-PCRs. Two-tailed, equal-
sample variance Student’s t-tests were used to calculate the P values: ⁄⁄P < 0.01.
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Considering that (i) NS1 interacts with Stau1 in this study and
previous report [6] and (ii) Stau1 is involved in cellular mRNA de-
cay pathway, SMD [9,11–14], it is plausible that NS1 modulates
SMD efﬁciency. To investigate the functional involvement of NS1
in SMD, we analyzed the levels of krüppel-like factor 2 (KLF2)
mRNA and interleukin-7 receptor (IL7R) mRNA, both of which
are endogenous SMD substrates [13–15], using quantitative real-
time RT-PCR (qRT-PCR) after expression of NS1. For comparison,
we also monitored the levels of COMM domain containing 7 (COM-
MD7) and isoleucine-tRNA synthetase (IARS) mRNA, both of which
are endogenous NMD substrates [16]. The expression level of
3xFLAG-NS1 was determined by Western blotting (Fig. 2A). The re-sults of qRT-PCRs showed that expression of NS1 increased the lev-
els of SMD substrates, KLF2 and IL7R mRNAs by 2-fold (Fig. 2B
and C). On the other hand, the level of NMD substrates, IARS and
COMMD7 mRNAs were not signiﬁcantly changed (Fig. 2D and E),
indicating that NS1 inhibits SMD efﬁciency, but not NMD
efﬁciency.
To further clarify the effect of NS1 on NMD, we employed the
well-known NMD reporter mRNAs, WT or PTC-containing b-globin
(Gl) mRNAs and glutathione peroxidase 1 (GPx1) mRNAs [33,34].
HeLa cells were transiently co-transfected with three plasmids:
(i) the NMD reporter plasmid, pmCMV-Gl or GPx1, which encodes
either PTC-free (Norm) or PTC-containing (Ter) Gl or GPx1 gene, (ii)
the reference plasmid phCMV-MUP, which serves as a loading con-
trol, and (iii) either p3xFLAG or p3xFLAG-NS1(WT). The results
A C
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Fig. 3. Expression of NS1(WT) and NS1(1-73) inhibits rapid mRNA degradation elicited by tethered Stau1. (A) Schematic representation of tethering reporter and effector
proteins used in our study. (B–D) HeLa cells were transiently co-transfected with (i) reporter plasmid pcb-6bs, (ii) an effector plasmid expressing MS2-HA or MS2-HA-Stau1,
(iii) the reference plasmid phCMV-MUP, and (iv) plasmid expressing 3xFLAG, 3xFLAG-NS1(WT) or 3xFLAG-NS1 deletion variants. Two days after transfection, protein and
RNA were puriﬁed and analyzed. (B) Western blotting of effector proteins using a-HA antibody. Cellular b-actin served as a control for variations in protein loading. (C)
Western blotting of NS1(WT) and its deletion variants using a-FLAG antibody. (D) qRT-PCR of b-6bs mRNA. The levels of b-6bs mRNA were normalized to the level of MUP
mRNA. The normalized levels of b-6bs mRNA that were obtained in the presence of MS2-HA were set to 100%. ⁄⁄P < 0.01.
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were expressed (Fig. 2F), NMD of PTC-containing Gl and GPx1
mRNA was not affected by expression of NS1 (Fig. 4G and H). All
these results suggest that NS1 inhibits SMD but not NMD.
3.3. Expression of NS1(WT) and NS1(1-73) inhibits rapid mRNA
degradation triggered by tethered Stau1
To further conﬁrm the role of NS1 in SMD and determine the
minimal region of NS1 required for SMD inhibition, we employed
the artiﬁcial tethering system using the bacteriophage MS2 coat
protein (MS2) and MS2-binding RNA sequences [13,16,32]. When
Stau1 is artiﬁcially tethered downstream of a translation stop co-
don, the tethered Stau1 recruits Upf1 and consequently triggers ra-
pid degradation of the reporter mRNA [13]. For these experiments,
HeLa cells were transiently transfected with four plasmids: (i) a
tethering reporter plasmid, pcb-6bs [32] that encodes the genomic
sequence of b-globin gene followed by six tandem repeats of the
MS2-binding site within the 30UTR (Fig. 3A), (ii) an effector plasmid
expressing MS2-HA or MS2-Stau1 (Fig. 3A), (iii) the reference plas-
mid phCMV-MUP, which served as a loading control, and (iv) plas-
mid expressing 3xFLAG, 3xFLAG-NS1(WT) or 3xFLAG-NS1 deletion
variants.
The sufﬁcient expression of effector proteins (Fig. 3B) and com-
parable expressions of 3xFLAG-NS1(WT) and its deletion variants
(Fig. 3C) were demonstrated by Western blotting. qRT-PCR of b-
6bs mRNA showed that, consistent with previous reports showingrapid mRNA degradation by tethered proteins [13,16], tethering of
MS2-HA-Stau1 reduced the level of b-6bs mRNA to 39%, compared
with tethering of MS2-HA (Fig. 3D). Intriguingly, the expression of
3xFLAG-NS1(WT) and 3xFLAG-NS1(1-73) signiﬁcantly inhibited
rapid degradation of b-6bs mRNA elicited by tethered Stau1
(Fig. 3D). On the other hand, the expression of 3xFLAG-NS1(74-
207) and 3xFLAG-NS1(74-230) had a marginal effect on degrada-
tion of b-6bs mRNA elicited by tethered Stau1. Of note, a rapid
mRNA degradation elicited by tethered Upf2, which is speciﬁcally
involved in NMD but not SMD [13,15], was not affected by expres-
sion of NS1 (Supplementary Fig. S1). Taken together with our
observations that an N-terminus of NS1 interacts with Stau1
(Fig. 1) and expression of NS1 inhibits SMD (Fig. 2), all these data
indicate that an N-terminal RBD of NS1 interacts with Stau1 and
is sufﬁcient for inhibiting SMD efﬁciency.
3.4. NS1 promotes the dissociation of Upf1 from Stau1 complex
Considering that (i) SMD requires Upf1, which is recruited via
its interaction with Stau1 [13,15,29] and (ii) NS1 binds to Stau1
(Fig. 1) and inhibits SMD (Figs. 2 and 3), it is likely that the ex-
pressed NS1 affects the interaction between Upf1 and Stau1. To ad-
dress this possibility, HEK293T cells were transiently co-
transfected with plasmids expressing Stau155-HA3, Myc-Upf1,
and either p3xFLAG or p3xFLAG-NS1. The sufﬁcient expression of
3xFLAG-NS1 was demonstrated by Western blotting (Fig. 4A).
The results of IPs using a-HA antibody revealed that Myc-Upf1
A B
C
Fig. 4. NS1 promotes the release of Upf1 from Stau1-containing complex. (A and B) IP of Stau155-HA3. HEK293T cells were transiently co-transfected with Stau155-HA3, Myc-
Upf1, and either 3xFLAG or 3xFLAG-NS1. (A) Western blotting of NS1 using a-FLAG antibody. (B) IPs were performed using a-HA antibody or rat IgG. The levels of co-
immunoprecipitated Myc-Upf1 were normalized to the level of immunoprecipitated Stau155-HA3. The normalized level of co-immunoprecipitated Myc-Upf1 in the absence
of NS1 was arbitrarily set to one. (C) Model for the regulation of SMD during inﬂuenza viral infection of. P, phosphate group.
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ence of NS1 (Fig. 4B). Of note, the levels of Upf1 and its phosphor-
ylation were not affected by expression of NS1 (Supplementary
Fig. S2). All our results suggest that NS1 promotes the release of
Upf1 from Stau1-containing complex.
4. Discussion
In this study, we demonstrate using IP experiments that the
full-length and N-terminal region of NS1 are sufﬁcient for binding
to Stau1 (Fig. 1). Our observation of the interaction between NS1
and Stau1 is consistent with the previous report [6]. However,
the previous group failed to observe an interaction between an
N-terminal region of NS1 spanning amino acids 1-81 and Stau1.
They also failed to observe an interaction between a remaining
part of NS1 spanning amino acids 82-238 and Stau1. On the other
hand, a weak interaction between NS1 spanning amino acids 1-113
or amino acids NS1 1-170 and Stau1 was observed [6], consistent
with our ﬁndings (Fig. 1). This discrepancy may be due to the dif-
ference in the tested N-terminal fragments: NS1(1-73) in our study
and NS1(1-81) in the previous report [6]. The region spanning 74-
81 amino acids in NS1 may have an inﬂuence on proper folding of
NS1 fragment, consequently affecting its association with Stau1.
Alternatively, the discrepancy may be due to the difference in
the used antibodies: antibodies anti-NS1 and anti-Stau1 in the pre-
vious study and anti-tag antibodies in our study.
We also demonstrate using endogenous SMD and NMD sub-
strates that NS1 inhibits SMD efﬁciency but not NMD efﬁciency
(Fig. 2). In addition, our tethering analysis showed that NS1(1-
73) is sufﬁcient for inhibition of rapid mRNA degradation elicited
by tethered Stau1 (Fig. 3). The inhibitory role of NS1 in SMD is
due to its ability to promote the dissociation of Upf1–Stau1
(Fig. 4A and B). Considering that expression of NS1 had no signiﬁ-cant effect on the levels of Upf1 protein and its phosphorylation
(Supplementary Fig. S2), it is likely that NS1 competes with Upf1
for binding to Stau1.
Based on our observations, we propose the following model
(Fig. 4C). Under the normal (uninfected) conditions, Stau1 binds
to the SBS at the 30UTR of target mRNAs, so as to trigger rapid
mRNA degradation. On the other hand, upon inﬂuenza viral infec-
tion, NS1 binds to Stau1 via an N-terminus of NS1 (Fig. 1). This
interaction promotes the release of Upf1 from Stau1-containing
complex (Fig. 4A and B). As a consequence, SMD-targeted mRNAs
would be stabilized and translated. Considering the previous re-
ports that NS1–Stau1 interaction is important for inﬂuenza viral
replication [7,8], the stabilization of SMD substrates by NS1
would make cellular environment more favorable for viral repli-
cation. For the complete understanding on the molecular role of
NS1 in SMD during viral infection, future studies should identify
the exact SMD substrates, which are regulated by NS1 upon viral
infection. Such SMD substrates as well as NS1–Stau1 interaction
might be considered as a novel target for the development of
antiviral drugs.
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